Palestinian Medical and Pharmaceutical Journal (Pal. Med. Pharm. J.)

Journal metrics

Journal metrics

Metrics and turnaround details

First decision 7 Days
Submission to acceptance 45 Days
Acceptance to publication 14 Days
Acceptance rate 8%

Scopus

Scopus profile

This journal is indexed in Scopus. Use these metrics for a quick publishing snapshot, then open the Scopus page for the authoritative profile.

Scopus
Palestinian Medical and Pharmaceutical Journal (Pal. Med. Pharm. J.) Indexed in Scopus since 2022
CiteScore 1.0
Indexed since 2022

SCImago

SCImago Journal Rank preview

Use SCImago when you want a quick visual view of the journal ranking profile and external discoverability signals.

Palestinian Medical and Pharmaceutical Journal (Pal. Med. Pharm. J.) SCImago Journal & Country Rank

DOAJ

Directory of Open Access Journals listing

The DOAJ record is useful for readers, librarians, and authors who want a direct open-access directory entry for the journal.

DOAJ
Palestinian Medical and Pharmaceutical Journal (Pal. Med. Pharm. J.) Open directory record
In Press Original full research article

Seroprevalence of Measles and Mumps Antibodies among Medical and Paramedical Students at An-Najha National University, Palestine (2020-2021)

Published
2026-06-02
Full text

Keywords

  • Palestine
  • Medical Students
  • Measles
  • Seroprevalence
  • Mumps

Abstract

Objective: This study assessed measles and mumps seroprevalence among medical and paramedical students at An-Najah National University, Nablus, Palestine, a group at elevated occupational risk. Methods: In this cross-sectional study, serum samples from 401 students (aged 18-23 years) were analyzed for measles-specific and mumps-specific IgG antibodies using quantitative ELISA. Participants completed questionnaires detailing MMR vaccination history and demographics. Key Findings: Measles seropositivity was 66.8% (268/401), mumps seropositivity was 76.3% (306/401), and combined measles and mumps seropositivity was 54.1% (217/401). Seropositivity for measles antibodies showed significant associations with age and gender. Conclusion: Seroprevalence levels for measles and mumps antibodies were suboptimal in this cohort of future healthcare workers. Given their heightened exposure risk, a booster vaccination strategy is recommended. Further investigation is warranted to elucidate the factors contributing to low immunity. Recommendations: A booster vaccination strategy is recommended.

Article history

Received
2025-11-20
Accepted
2026-05-01
Available online
2026-06-02
قيد النشر بحث أصيل كامل

Seroprevalence of Measles and Mumps Antibodies among Medical and Paramedical Students at An-Najha National University, Palestine (2020-2021)

Published
2026-06-02
البحث كاملا

الكلمات الإفتتاحية

  • Palestine
  • Medical Students
  • Measles
  • Seroprevalence
  • Mumps

الملخص

Objective: This study assessed measles and mumps seroprevalence among medical and paramedical students at An-Najah National University, Nablus, Palestine, a group at elevated occupational risk. Methods: In this cross-sectional study, serum samples from 401 students (aged 18-23 years) were analyzed for measles-specific and mumps-specific IgG antibodies using quantitative ELISA. Participants completed questionnaires detailing MMR vaccination history and demographics. Key Findings: Measles seropositivity was 66.8% (268/401), mumps seropositivity was 76.3% (306/401), and combined measles and mumps seropositivity was 54.1% (217/401). Seropositivity for measles antibodies showed significant associations with age and gender. Conclusion: Seroprevalence levels for measles and mumps antibodies were suboptimal in this cohort of future healthcare workers. Given their heightened exposure risk, a booster vaccination strategy is recommended. Further investigation is warranted to elucidate the factors contributing to low immunity. Recommendations: A booster vaccination strategy is recommended.

Article history

تاريخ التسليم
2025-11-20
تاريخ القبول
2026-05-01
Available online
2026-06-02